Adam JacksonTwo years after its rocky start, New York’s legal cannabis market may be finally hitting its stride, with monthly sales soaring to $131 million across 215 dispensaries – a big shift from the single store that opened its doors in Manhattan’s East Village in late 2022.
The surge has created an unusually concentrated market where local brands are thriving and commanding premium prices, according to a new analysis from cannabis research firm Zuanic & Associates. While New York dispensaries remain sparse versus other legal states – just 11 stores per million residents versus California’s 32 – they’re proving remarkably productive, averaging $7 million in annual revenue per location.
“New York’s legal rec cannabis market is now at a $1.6 billion run rate,” Pablo Zuanic, the firm’s lead analyst, said. He acknowledged the recreational market’s challenges with red tape, illicit competition, and limited product selection but pointed to the market’s recovery in recent quarters.
Local players have carved out strong positions across product categories. In flower, which makes up 35% of sales, homegrown brand Dank By Definition leads with 12.5% market share and charges a hefty premium at $14.12 per gram. But it's facing growing competition from PharmaCann, one of the largest private multistate operators, whose LivWell and Matter brands have captured 18% of flower sales by targeting more value-conscious consumers.
The edibles segment tells an even more interesting story about brand power. Local manufacturer Off Hours commands nearly a quarter of sales, while California transplant Kiva has successfully exported its popular Camino brand to capture 19.4% of the market. That level of brand concentration – with top players controlling 40% or more of certain categories – is unusual for such a young market.
The combination of strong pricing and brand loyalty could attract more established cannabis companies looking to break into New York, either directly or through brand licensing deals. While most large multistate operators have limited presence here so far, the success of out-of-state brands like Kiva's Camino in edibles and Rove in vapes shows there's room for newcomers who understand the market's premium positioning.
“Given strong pricing in the legal New York cannabis market, higher than normal brand concentration (for a new market), and what we would characterize as still volatile market share trends, we see an opportunity for MSOs to eventually build presence in the state,” Zuanic noted. “If they can make it there…”
